The U.S. Justice Department is demanding Shire cough up $350 million to settle a Dermagraft marketing probe, citing “flagrant and systemic kickback activity.”

Allergan CEO Brent Saunders is tired of hearing from investors that chin-fat buster Kybella’s launch isn’t going as well as those of his company's other…

AbbVie joined the 10% price-hike pledge Wednesday, following Allergan and Novo Nordisk, as the drug pricing debate sent biopharma shares reeling once again.…

Merck & Co. is another step closer to eclipsing its I-O competitors thanks to an unexpectedly quick filing for a new Keytruda-chemo combo.

After a year of rapid growth, including business wins from GSK, Bayer and Gilead, McCann Health has scooped Geline Midouin from digital agency 360i to serve as…

Sanofi's Genzyme CEO David Meeker has one key objective for the company's new atopic dermatitis drug launch—and it isn't about sales numbers.

AbbVie’s Humira finished the last month of 2016 in much the same way it did most of the year—as the No. 1 national TV ad spender among pharma brands.

Pharma companies spent $2.2 billion last year on TV ads for their 20 top brands, and nine of the biggest spenders each went over $100 million, according to…

Takeda plans to shell out $5.2 billion for the kind of deal most major drugmakers want: Ariad, its leukemia drug Iclusig and a pipeline with near-term…

Marketing